検索結果 101 - 120 結果 / 2,515 検索語 'harm is (((((remove. OR evolveddsssdss.) OR evolves.) OR involves.) OR involved.) OR evolved.)', 処理時間: 0.31秒 結果の絞り込み
  1. 101
  2. 102
  3. 103
  4. 104
  5. 105
  6. 106
  7. 107
  8. 108
  9. 109
  10. 110

    Trends in the valuation of injury involving the face: an analysis on trial in Rio Grande do Sul, Brazil 著者: Gabriela Cauduro da ROSA (4647883)

    出版事項 2020
    “…To measure the damage, the assessment of the bodily harm is required. Objective To analyze jurisprudential characteristics involving the valuation of the damage related to facial trauma, highlighting trends Methods It was analyzed secondary data, which are public domain, of the precedents of the Court of Justice of Rio Grande do Sul State from 2008 to 2016. …”
  11. 111
  12. 112
  13. 113

    Table_3_Early Response to the Plant Toxin Stenodactylin in Acute Myeloid Leukemia Cells Involves Inflammatory and Apoptotic Signaling.xlsx 著者: Daniele Mercatelli (6031271)

    出版事項 2020
    “…<p>Stenodactylin, a highly toxic type 2 ribosome-inactivating protein purified from the caudex of Adenia stenodactyla Harms, is a potential anticancer drug candidate. …”
  14. 114

    Table_1_Early Response to the Plant Toxin Stenodactylin in Acute Myeloid Leukemia Cells Involves Inflammatory and Apoptotic Signaling.xlsx 著者: Daniele Mercatelli (6031271)

    出版事項 2020
    “…<p>Stenodactylin, a highly toxic type 2 ribosome-inactivating protein purified from the caudex of Adenia stenodactyla Harms, is a potential anticancer drug candidate. …”
  15. 115

    Table_2_Early Response to the Plant Toxin Stenodactylin in Acute Myeloid Leukemia Cells Involves Inflammatory and Apoptotic Signaling.xlsx 著者: Daniele Mercatelli (6031271)

    出版事項 2020
    “…<p>Stenodactylin, a highly toxic type 2 ribosome-inactivating protein purified from the caudex of Adenia stenodactyla Harms, is a potential anticancer drug candidate. …”
  16. 116
  17. 117
  18. 118

    Patient Involvement in Preparing Clinical Research Peer-Reviewed Publications or Results Summaries: A Systematic Review 著者: Karen L. Woolley (4910764)

    出版事項 2018
    “…<div><b>Objective</b></div><div>Although patient involvement in results reporting is being encouraged, relevant evidence must be assessed before developing best practice guidelines. …”
  19. 119
  20. 120